19-1220474-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PM2
The NM_000455.5(STK11):c.566C>G(p.Thr189Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T189I) has been classified as Likely benign.
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.566C>G | p.Thr189Ser | missense_variant | Exon 4 of 10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.566C>G | p.Thr189Ser | missense_variant | Exon 4 of 9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.1833C>G | non_coding_transcript_exon_variant | Exon 5 of 11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.566C>G | p.Thr189Ser | missense_variant | Exon 4 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.566C>G | p.Thr189Ser | missense_variant | Exon 4 of 9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748.3 | c.194C>G | p.Thr65Ser | missense_variant | Exon 6 of 12 | 3 | ENSP00000477641.2 | |||
STK11 | ENST00000593219.6 | n.*391C>G | non_coding_transcript_exon_variant | Exon 5 of 11 | 3 | ENSP00000466610.1 | ||||
STK11 | ENST00000593219.6 | n.*391C>G | 3_prime_UTR_variant | Exon 5 of 11 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt STK11 protein function. This variant has not been reported in the literature in individuals affected with STK11-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 189 of the STK11 protein (p.Thr189Ser). -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.T189S variant (also known as c.566C>G), located in coding exon 4 of the STK11 gene, results from a C to G substitution at nucleotide position 566. The threonine at codon 189 is replaced by serine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at